AM�-��������� ������� ������ �AM��� �� �����-��z�� �� � m��� ���ul���� �f �����y h�m��������. O������l��� (OC), which is produced specifically by mature osteoblasts, is stored in bone matrix, strongly binds to hydroxyapatite and is released into the circulation, has been recognized as a marker of bone metabolism. It has recently been shown that OC released from osteoblasts influences energy metabolism as � h��m���. W� ������u�ly �������� �h�� ��������hy������ �T 3 � stimulates the synthesis of OC in osteoblast-like MC3T3-E1 ��ll�. I� �h� ������� ��u�y, w� ������������ wh��h�� AM�� ������������ �� T 3 -stimulated OC synthesis in osteoblasts. T 3 ��m�-���������ly ���u��� �h� �h���h��yl����� �f �h� AM��α-subunit (Thr-172), whereas T 3 f��l�� �� ���u�� �h� �h���h��yl����� �f AM��α-subunit (Ser-485), AMPKβ-subunit (Ser-108) and AMPKβ-subunit (Ser-182). Both the release and the mRNA expression of OC induced by T 3 w��� significantly inhibited by compound C, an AMPK inhibitor. C�m��u�� C �u�������� �h� T 3 -���u��� �h���h��yl����� of acetyl-CoA carboxylase, a direct substrate of AMPK. T 3 -stimulated OC release was significantly reduced in AMPK�������w� ��ll� u���� AM��-��RNA. Th��� ���ul�� ������ly �u����� �h�� AM�� ��������ly ���ul���� T 3 -���mul���� OC synthesis in osteoblasts.
Introduction
Bone metabolism is a highly coordinated process performed mainly by two types of functional cells, osteoblasts and osteoclasts. The former is responsible for bone formation and the latter for bone resorption. At present, it is well recognized that osteoblasts play a pivotal role in the regulation of bone ���������� �h��u�h �������� ��������� �f �u�l��� f�����-κB ligand (RANKL) expression which is responsive to numerous bone resorptive stimuli (1) . Osteoblasts, which are differentiated from mesenchymal progenitors, express various cell �y��-�����f�� m������ �u���� �h� ��ff����������� �������. Osteocalcin (OC) is a bone-specific protein that is modified post-translationally by vitamin K-dependent γ-carboxylation, known as bone Gla-protein (2) . It is well known that OC is synthesized specifically in osteoblasts; therefore, OC is recognized as one of the markers of the mature osteoblast phenotype. In contrast, OC-deficient mice reportedly display an increase in bone formation without impairing bone resorption, suggesting that OC is a determinant of moderate bone formation (3) . In addition, it has recently been shown that un-carboxylated OC released from osteoblasts regulates energy metabolism through acting on pancreatic β-��ll� �� �������� ���ul�� �y��h����, ������y��� �� �������� ����������� and skeletal myocytes to glucose uptake (4, 5) . These findings lead us to speculate that bone, as an endocrine organ, plays a vital role also in energy metabolism through the release of OC. However, the exact mechanism underlying OC synthesis in osteoblasts remains to be clarified.
Thy���� h��m��� �� �� �m������� ���ul���� �f ���l���l function as well as whole body metabolism. Thyroid hormone excess, namely hyperthyroidism, is a major cause of secondary ������������ �6�. I� �h� ����� �f hy����hy������m, �h� ���um l���l� �f �l��l��� �h���h����� ��� OC, m������ �f �h� osteoblast phenotype, are elevated as well as the excretion of pyridinoline and hydroxypyridinoline cross-link, which reflects bone resorption (6) . It is known that an imbalance in bone remodeling causes the loss of bone mass by hyperthy������m �6�. Th� ��������� f�� ��������hy������ �T 3 ), a member of the steroid hormone receptor superfamily, are expressed in osteoblasts (6) . It has been reported that thyroid hormone ���mul���� �l��l��� �h���h����� �������y ��� ��������� �f OC and insulin-like growth factors in osteoblasts and that it modulates proliferation of osteoblasts (6) (7) (8) (9) . In our previous studies (10,11), we reported that p38 mitogen-activated protein (MAP) kinase but not p44/p42 MAP kinase, is involved in (12) . AMPK h�� �m����� ���� �h� l��� ������ �� � ��y ������� m��h����m �� �h� ���ul����� �f ��llul�� �����y h�m�������� �13-15�. Th� enzyme is activated by a variety of physiological and pathol�����l �������� wh��h �������� �h� �������llul�� AM�:AT� ratio, either by increasing ATP consumption or by decreasing AT� ����u����� �� m�mm�l��� ��ll�. A�������� AM�� acts to restore cellular energy balance by ATP-generating pathways such as fatty acid oxidation, while simultaneously inhibiting ATP utilizing pathways. Regarding bone metabol��m, m��f��m��, wh��h ��� �������� AM�� �16�, ��������ly increases markers of osteoblast differentiation including OC mRNA expression, and enhances mineralization in osteoblastlike MC3T3-E1 cells (17) . It has recently been reported that AMPK activation regulates bone formation and bone mass (18) . These previous findings led us to speculate that AMPK influences bone metabolism through the functional modulation of osteoblasts. We previously demonstrated that AM�� �l�y� � ��l� �� �h� �y��h���� �f ����ul�� �����h�l��l growth factor or interleukin-6 in osteoblasts (19, 20) . However, the exact role of AMPK in bone metabolism, particularly in osteoblasts, has not yet been fully elucidated.
In the present study, we investigated the mechanism behind T 3 -stimulated OC synthesis in osteoblast-like MC3T3-E1 ��ll� ��� �h� ����l��m��� �f AM�� �� OC �y��h����. W� h��� ��m��������� �h�� AM�� ��������ly ���ul���� T 3 -���mul���� OC �y��h���� �� �h��� ��ll�. ). An ECL Western blotting detection system was purchased from GE Healthcare, Ltd. (Buckinghamshire, UK). Control short interfering RNA (siRNA; Silencer Negative Control no. 1 ��RNA� ��� AM��-��RNA w��� �u��h���� f��m Q����� (Hilden, Germany). siLentFect was purchased from Bio-Rad (Hercules, CA, USA). TRIz�l ������� ��� Om�������� R������ Transcriptase kit were purchased from Invitrogen (Carlsbad, CA, USA) and Qiagen, respectively. Fast-start DNA Master SYBR-Green I was purchased from Roche Diagnostics GmbH (Mannheim, Germany). Other materials and chemicals were obtained from commercial sources. Compound C was dissolved in dimethyl sulfoxide. The maximum concentration of dimethyl sulfoxide was 0.1%, which did not affect the assay for OC or detection of the protein level by western blot analysis.
Materials and methods

Materials
Cell culture. Cloned osteoblast-like MC3T3-E1 cells derived from newborn mouse calvaria (23) were maintained as previously described (24) . Briefly, the cells were cultured in α-m���mum ��������l m���um �α-MEM) containing 10% fetal calf serum (FCS) at 37˚C in a humidified atmosphere of 5% CO 2 /95% air. The cells were seeded into 35-mm (5x10 4 � �� 90-mm (2x10 5 � ���m���� ���h�� �� α-MEM containing 10% FCS. After 5 days, the medium was exchanged for α-MEM containing 0.3% FCS. The cells were used for experiments after 48 h.
OC assay. The cultured cells were stimulated by T 3 �� 1 ml �f α-MEM containing 0.3% FCS for the indicated periods. The conditioned medium was collected at the end of the incubation, and the OC concentration was measured by an OC ELISA kit. Wh�� ���������, �h� ��ll� w��� ���������� w��h �����u� ����� �f ��m��u�� C f�� 60 m��.
Western blot analysis. Western blot analysis was performed as previously described (25) . The cultured cells were stimulated by T 3 �� ��h��l� �� α-MEM containing 0.3% FCS for the ��������� �������. Wh�� ���������, �h� ��ll� w��� ���������� w��h �����u� ����� �f ��m��u�� C f�� 60 m��. Th� ��ll� were washed twice with phosphate-buffered saline and then lysed, homogenized and sonicated in a lysis buffer containing 62.5 mM Tris/HCl; pH 6.8, 3% sodium dodecyl sulfate (SDS), 50 mM dithiothreitol and 10% glycerol. SDS-polyacrylamide gel electrophoresis (PAGE) was performed according to Laemmli (26) on 10% polyacrylamide gel. The protein was fractionated and transferred onto Immun-Blot PVDF membranes (Bio-Rad). Membranes were blocked with 5% fat-free dry milk in Tris-buffered saline-Tween-20 (TBS-T; 20 mM Tris/HCl, pH 7.6, 137 mM NaCl, 0.1% Tween-20) for 2 h before incubation with the primary antibodies. The following antibodies were used: phospho-specific AMPKα �Th�-172� antibodies, phospho-specific AMPKα (Ser-485) antibodies, AM��α antibodies, phospho-specific AMPKβ (Ser-108) antibodies, phospho-specific AMPKβ (Ser-182) antibodies, AM��β antibodies, phospho-specific acetyl-CoA carboxylase antibodies and GAPDH antibodies as primary antibodies. Peroxidase-labeled antibodies raised in goat against rabbit IgG [Kirkegaard & Perry Laboratories (KPL), Inc., Gaithersburg, MD, USA] were used as secondary antibodies. The primary and secondary antibodies were diluted at 1:1,000 with 5% fatfree dry milk in TBS-T. Peroxidase activity on the membrane was visualized on X-ray film by means of the ECL Western blotting detection system.
Real-time RT-PCR.
Th� �ul�u��� ��ll� w��� ���������� w��h compound C for 60 min and stimulated by T 3 f�� �h� ��������� periods. Total RNA was isolated and transcribed into cDNA u���� TRIz�l ������� ��� Om�������� R������ T������������ ���. R��l-��m� RT-�CR w�� ���f��m�� u���� � L��h�Cy�l�� system (Roche Diagnostics) in capillaries and Fast-Start DNA Master SYBR-Green I provided with the kit. Sense and antisense primers were synthesized based on the report of Zh��� et al (27) for mouse OC mRNA and GAPDH mRNA. The amplified products were determined by melting curve ���ly��� ��� ������� �l������h������. OC mRNA l���l� w��� normalized with those of GAPDH mRNA. Statistical analysis. The data were analyzed by ANOVA followed by the Bonferroni method for multiple comparisons between pairs, and a P<0.05 was considered to indicate a statistically significant result. All data are presented as the means ± SEM of triplicate independent determinations.
Results
Effects of T 3 on the phosphorylation of AMPK in MC3T3-E1
cells. I� ����� �� ����������� wh��h�� T 3 ��������� AM�� �� osteoblasts, we first examined the effects of T 3 �� �h� �h��-phorylation of AMPK in osteoblast-like MC3T3-E1 cells. T 3 m�����ly ���u��� �h� �h���h��yl����� �f �h� AM��α-subunit �Th�-172� �F��. 1�. Th� �ff��� �f T 3 �� �h� �h���h��yl����� �f �h� AM��α-subunit (Thr-172) reached its peak at 60-90 min ��� ��������� �h����f���. H�w����, T 3 f��l�� �� �ff��� �h� �h���h��yl����� l���l� �f AM��α-subunit (Ser-485), AMPKβ-subunit (Ser-108) and AMPKβ-subunit (Ser-182) (Fig. 1) .
Effect of compound C on the phosphorylation of acetyl-CoA carboxylase in MC3T3-E1 cells.
I� �� ������lly �������z�� that acetyl-CoA carboxylase, which catalyzes an important step in lipid synthesis, is a direct substrate of AMPK (15) . We confirmed that T 3 m�����ly ���mul���� �h� �h���h��yl����� of acetyl-CoA carboxylase in MC3T3-E1 cells (Fig. 2) . The �ff��� �f T 3 on the acetyl-CoA carboxylase phosphorylation ����h�� ��� ���� w��h�� 2 h ��� ��������� �h����f���. W� found that compound C, an inhibitor of AMPK (16), markedly �u�������� �h� T 3 -���mul���� �h���h��yl����� �f ����yl-C�A carboxylase (Fig. 3) .
Effect of compound C on the T 3 -stimulated OC release in MC3T3-E1 cells.
I� ����� �� �l���fy �h� ����l��m��� �f AM�� �� �h� T 3 -stimulated OC release in osteoblasts, we next exam-���� �h� �ff��� �f ��m��u�� C �� �h� ��l���� �f OC ���mul���� by T 3 �� MC3T3-E1 ��ll�. C�m��u�� C, wh��h �l��� ��� ��� affect the OC levels, significantly suppressed the T 3 -���mul���� OC release in a time-dependent manner (Fig. 4) . The inhibi���y �ff��� �f ��m��u�� C w�� ����-��������� �� �h� ����� between 0.3 and 10 µM (Fig. 5) . The maximum effect of compound C was observed at 10 µM, which resulted in ~90% inhibition compared to the OC level with T 3 �l���. 
Effect of compound C on the T 3 -induced OC mRNA expression in MC3T3-E1 cells.
It has been shown that T 3 ���u��� �h� mRNA expression of OC in osteoblasts (9) . In order to inves-������ wh��h�� �h� �u��������� �f T 3 -���mul���� OC �y��h���� by compound C is mediated through transcriptional events, we next examined the effect of compound C on T 3 -���u��� OC mRNA expression. Compound C, which by itself had little effect on the basal level of OC mRNA, significantly reduced �h� T 3 -���u��� l���l �f OC mRNA �F��. 6�.
Effect of AMPK-siRNA on T 3 -stimulated OC release in MC3T3-E1 cells.
W� fu��h�� ������������ �h� �ff��� �f AM�� knockdown on the OC release stimulated by T 3 �� MC3T3-E1 ��ll�. I� ��m������� w��h �h� ������l ��ll�, �h� T 3 -���mul���� OC release was significantly diminished in AMPK-knockdown cells by AMPK-siRNA (Fig. 7) . Approximately 60% suppres-���� �f �h� T 3 -���mul���� OC ��l���� ���ul��� f�ll�w��� �h� �����m��� w��h AM��-��RNA.
Discussion
I� �h� ������� ��u�y, w� �h�w�� �h�� T 3 ���u��� �h� �h���h��y-lation of AMPK in osteoblast-like MC3T3-E1 cells, using phospho-specific AMPKα-subunit (Thr-172) antibodies. It is ������lly �������z�� �h�� �h� �h���h��yl����� �f Th�-172 �� �h� AM��α-subunit is necessary for AMPK activity (12, 28) . Th���f���, �� �� l���ly �h�� T 3 ���mul���� �h� ���������� �f AM�� in osteoblast-like MC3T3-E1 cells. To the best of our knowledge, this is probably the first report showing the involvement �f AM�� �� �h� �������llul�� �����l��� �f T 3 in osteoblasts. O� �h� ��h�� h���, T 3 f��l�� �� ���u�� �h� �h���h��yl����� �f AM��α-subunit (Ser-485). It seems unlikely that the phosphorylation of Ser-485 in the α-subunit is involved in T 3 -���u��� AM�� ���������� �� MC3T3-E1 ��ll�. I� ��������, w� f�u�� �h�� AM��β-subunits (Ser-108 and Ser-182), which were phosphorylated without stimulation, were barely affected by T 3 . It has been shown that phosphorylation at Ser-108 of �h� AM��β-subunit is required for the activation of AMPK, while phosphorylation of Ser-182 affects AMPK localization (29) . Moreover, we showed here that the phosphorylation of acetyl-CoA carboxylase, known as a direct substrate of AMPK (30) , was significantly induced by T 3 . Th� ��m� ��u��� �f �h� �h���h��yl����� �f AM��α-subunit (Thr-172) stimulated by T 3 appears to be more rapid than that of acetyl-CoA carboxylase. Furthermore, we found that compound C, an AMPK inhibitor (16) , reduced the phosphorylation levels of acetyl-CoA carboxylase by T 3 . It is probable that the inhibitory effect of compound C is exerted through the suppression of AMPK. Based on our findings, it is most likely that T 3 ����-����ly ���ul���� AM�� �������y ��� �h� �h���h��yl����� �f �h� AM��α-subunit (Thr-172) in osteoblast-like MC3T3-E1 cells.
W� ������u�ly ��m��������� �h�� T 3 ���u��� OC �y��h���� which is a marker of osteoblast differentiation in osteoblast-like MC3T3-E1 cells (10, 11) . Thus, we next investigated whether or ��� AM�� �� ����l��� �� �h� T 3 -���mul���� OC �y��h���� �� MC3T3-E1 ��ll�. W� �h�w�� �h�� �h� T 3 -���mul���� OC ��l���� was significantly suppressed by compound C, an inhibitor of AM�� �16�, �u�������� �h�� AM�� �� ����l��� �� �h� OC release induced by T 3 �� �h��� ��ll�. A��������lly, ��m��u�� C markedly reduced the OC mRNA expression induced by T 3 , �u�������� �h�� AM�� ���ul���� OC �y��h���� �� � ����� upstream of the transcriptional process. We further examined the effect of AMPK knockdown by siRNA on T 3 -���mul���� OC ��l���� ��� ��m��������� �h� �����m����� ���u����� �� T 3 -stimulated induction of OC by AMPK knockdown in the osteoblast-like MC3T3-E1 cells. Taking our findings into ����u��, �� �� m��� l���ly �h�� AM�� fu������� �� � �������� ���ul���� �� T 3 -stimulated OC synthesis in osteoblasts.
Thyroid hormone excess, or hyperthyroidism, is a major cause of secondary osteoporosis. Both bone formation and bone resorption are accelerated in the state of hyperthyroidism, and the predominance of bone resorption rather than bone formation results in the loss of bone mass (6) . On the other hand, deficiency of the thyroid hormone causes severe skeletal ���w�h ����������� �� ��f����. Th��� �l�����l ������ �������� �h� importance of the thyroid hormone in bone metabolism. Thus, �� �� ��������l �� �l���fy �h� ������� m��h����m �f T 3 ������, an active form of thyroid hormone, particularly in osteoblasts which promote bone formation and regulate bone resorption. OC, � γ-carboxylated calcium-binding protein, is generally recognized to be produced by mature osteoblasts (2) . It is well ���w� �h�� �h� ���um l���l �f OC �� �l������ �� �������� w��h hyperthyroidism (6) . OC-deficient mice reportedly develop hyperostosis (3), suggesting its crucial role in the bone remodeling process. Thus, our present findings demonstrating the AMPK-dependent OC release induced by T 3 ������� � ��w concept of bone metabolism. In addition, it has recently been shown that un-carboxylated OC released from osteoblasts as a bone-derived hormone regulates energy metabolism by ������ �� ���������� β-��ll� �� �������� ���ul�� �y��h����, �� ������y��� �� �������� ����������� ��� �� ���l���l my��y��� for glucose uptake in rodent (4, 5) . This significant effect of un-carboxylated OC has not yet been clarified in human; however, osteoblast-releasing OC may participate in whole body energy regulation. In addition, metformin, an AMPKactivating substance, has already been widely used as an agent for diabetes. AMPK plays a vital role as an energy sensor ���m����� �h� ����l��m��� �f ����u� ������� f��m m����-chymal cells such as muscle and bone. Taking our present findings into account as a whole, AMPK regulation of OC release by osteoblasts may be a therapeutic target for metabolic disorders. Further investigation is required to clarify the details of AMPK in bone metabolism. In conclusion, �u� ���ul�� ������ly �u����� �h�� AM�� ��������ly ���ul���� T 3 -stimulated OC synthesis in osteoblasts.
